About Carcinotech
Carcinotech is a company based in Edinburgh (United Kingdom) founded in 2018. It operates as a B2B. Carcinotech has raised $7.35 million across 4 funding rounds from investors including Santander UK, Scottish Enterprise and Maven Capital Partners. The company has 1 employees. Carcinotech offers products and services including Biopsy Sourcing, 3D Tumor Development, and Oncology Assays. Carcinotech operates in a competitive market with competitors including Biocytogen, Applied StemCell, GenOway, Newcells Biotech and Interius Biotherapeutics, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website carcinotech.co.uk
- Social LinkedIn X
- Legal Name Carcinotech Ltd
- Date of Incorporation 31 Jul, 2018
- Jurisdiction EDINBURGH, MIDLOTHIAN, SCOTLAND
- Total Equity Funding$7.35M (USD)
in 4 rounds
- Latest Funding Round$5.3M (USD), Seed
Jan 2024
- InvestorsSantander UK
& 11 more
- Employee Count1
Products & Services of Carcinotech
Carcinotech offers a comprehensive portfolio of products and services, including Biopsy Sourcing, 3D Tumor Development, and Oncology Assays.
Sourcing tumor biopsies for oncology research and development.
Creating 3D-printed tumor models for drug testing applications.
Conducting assays to evaluate cancer treatments and therapies.
Funding Insights of Carcinotech
Carcinotech has successfully raised a total of $7.35M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $5.3 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.35M
- Total Rounds 4
- Last Round Seed — $5.3M
- Investors Count 12
All 4 funding rounds of Carcinotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $5.3M | Seed | – | Eos Advisory, Investing Women | |
| Apr 2022 | $2.05M | Seed | – | Tricapital | |
| Aug 2020 | – | Seed | – | – | – |
| Aug 2018 | – | Seed | – | Santander | – |
12 investors in total: 12 institutional.
Investors in Carcinotech
Carcinotech has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Santander UK, Scottish Enterprise and Maven Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in science and technology is managed by Eos. | 2014 | eos-advisory.com | St Andrews, Scotland | |
Early-stage investment is provided to promising Scottish entrepreneurs. | – | gabriel-is.com | Glasgow, Scotland | |
Venture capital fund focused on social impact companies | – | sisventures.com | Edinburgh, United Kingdom | |
Early-stage Scottish companies are supported with investment and expertise. | – | tricapital.co.uk | Melrose, United Kingdom | |
Female-led angel investment syndicate is focused on supporting women. | – | investingwomen.co.uk | Edinburgh, Scotland | |
Multiple sectors are targeted for private equity investments. | 2005 | mavencp.com | Birmingham, United Kingdom | |
An investment group focused on early-stage technology companies. | – | gabriel-investments.com | Philadelphia, United States | |
VC firm investing in the US | – | gabrielvp.com | San Mateo, United States | |
Delivers comprehensive investment services for clients. | 2019 | albaequity.com | Aberdeen, United Kingdom | |
Multiple courses and degrees are offered across diversified academic streams. | 1583 | ed.ac.uk | Edinburgh, United Kingdom |
Investor details for Carcinotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Carcinotech
11 people are tracked at Carcinotech (4 in leadership, 7 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Lorna Peers | Chief Financial Officer | Leadership |
Ishani Malhotra | Chief Executive Officer | Leadership |
Liam McFarlane | Head of Operations | Leadership |
Ian Waddell | Investment Director | Leadership |
Kamila Pawlicka | Scientific Manager | Team |
Phoebe O’brien | Operations & Admin Associate | Team |
Michaela Raab | Imaging Scientist | Team |
Stephen Mcrae | Senior Marketing Associate | Team |
Ben Kennedy | Senior Laboratory Technician | Team |
Rachel Bowman | Marketing Manager | Team |
Ellis Smith | Senior Development Scientist | Team |
Complete people profiles for Carcinotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Carcinotech
3 dated milestones of Carcinotech across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Carcinotech is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $5.3M.
Competitors of Carcinotech
Carcinotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, GenOway, Newcells Biotech and Interius Biotherapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics | |
| genoway.com | 1999 | Lyon, France | $11.55M | – | Provider of transgenic rodent models and customized cell lines for preclinical development | |
| newcellsbiotech.co.uk | 2014 | Newcastle Upon Tyne, United Kingdom | $14.43M | 22 | Induced pluripotent stem cell-derived organoid models are developed for research. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| insphero.com | 2009 | Schlieren, Switzerland | $35.02M | – | Cell-based assays and 3D microtissues for drug screening are developed. | |
| pandorum.com | 2011 | Bengaluru, India | $36.82M | 28 | Regenerative medicine and 3D tissues are developed for therapeutic uses. | |
| pearbio.com | 2017 | London, United Kingdom | $14.15M | 33 | Developer of microfluidic chip for cancer drug research | |
| vivodyne.com | 2021 | Philadelphia, United States | $117.69M | – | Developer of AI-based platform for lab-grown human tissues | |
| championsoncology.com | 1985 | Hackensack, United States | – | 230 | Drug response assays are performed using murine in vivo models. |
Detailed competitors of Carcinotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carcinotech
Complete news archive for Carcinotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Carcinotech
10 companies that operate in the same segment as Carcinotech (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – | |
Global leader for In Vitro Diagnostic | 1959 | Barcelona, Catalonia, Spain | – | USD 61.01 M | 346 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Carcinotech
Carcinotech was founded in 2018.
Carcinotech is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Carcinotech is a funded company, having raised a total of $7.35M across 4 funding rounds to date.
Carcinotech has 1 employees.
Carcinotech specializes in preclinical oncology services, utilizing 3D-bioprinted, patient-derived tumors to advance drug development and personalized treatments. They offer biopsy sourcing, tumor development, and oncology assays to support early drug discovery and testing. Based in the United Kingdom, they collaborate with biotech organizations and researchers to enhance cancer research efficiency and accuracy.
Carcinotech's top competitors include Biocytogen, Applied StemCell and Newcells Biotech.
Carcinotech offers Biopsy Sourcing, 3D Tumor Development, and Oncology Assays.
Carcinotech has 12 investors. Key investors include Santander UK, Scottish Enterprise, Maven Capital Partners, The University of Edinburgh, and Eos.
Carcinotech operates through Carcinotech Ltd.